
Pluristem Therapeutics Inc. has become Pluri Inc.
You are viewing our legacy website.
Click here to visit our new website
In-house commercial-scale manufacturing facility with a 3D bioreactor technology for cell expansion
In-house commercial-scale manufacturing facility with a 3D bioreactor technology for cell expansion